CD9 and neoplasm: Immunostaining was performed to assess both proliferative/stem cell (Nestin, Sox2, Ki67, Vimentin, SSEA1, CD133) and quiescent (Cd9 and Gfap) markers within the tumours (Supplementary Figure S5).